Zobrazeno 1 - 10 of 105 pro vyhledávání: '"Maik J Grundeken"'
1
Akademický článek
Admission lipoprotein-associated phospholipase A2 activity is not associated with long-term clinical outcomes after ST-segment elevation myocardial infarction.
Autor: Pier Woudstra, Peter Damman, Wichert J Kuijt, Wouter J Kikkert, Maik J Grundeken, Peter M van Brussel, An K Stroobants, Jan P van Straalen, Johan C Fischer, Karel T Koch, José P S Henriques, Jan J Piek, Jan G P Tijssen, Robbert J de Winter
Publikováno v: PLoS ONE, Vol 9, Iss 5, p e96251 (2014)
BACKGROUND: Lipoprotein-associated phospholipase A2 (Lp-PLA2) activity is a biomarker predicting cardiovascular diseases in a real-world. However, the prognostic value in patients undergoing primary percutaneous coronary intervention (pPCI) for ST-se
Externí odkaz: https://doaj.org/article/24a1b548da354adf84337f2e9715c24f
Zobrazit plný text záznamu
2
Contemporary techniques in percutaneous coronary intervention for bifurcation lesions
Autor: Takuya Mizukami, Maik J. Grundeken, Carlos Collet
Publikováno v: Expert Review of Cardiovascular Therapy. 16:725-734
Introduction: Treatment of coronary bifurcation lesions with contemporary state-of-the-art percutaneous coronary intervention (PCI) is still associated with higher rate of adverse cardiovascular events compared to non-bifurcation lesions. Bench testi
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ece406473b9a09712641bc01137d2822
https://doi.org/10.1080/14779072.2018.1523717
Zobrazit plný text záznamu
3
Five-year clinical follow-up of the STENTYS self-apposing stent in complex coronary anatomy: a single-centre experience with report of specific angiographic indications
Autor: J. G. P. Tijssen, R. J. de Winter, Pier Woudstra, Karel T. Koch, Joanna J. Wykrzykowska, R. J. Bekker, Huangling Lu, Maik J. Grundeken
Publikováno v: Netherlands Heart Journal
Netherlands heart journal, 26(5), 263-271. Bohn Stafleu van Loghum
Objectives We sought to investigate angiographic indications for the use of the STENTYS technique and evaluated the long-term safety and clinical efficacy of the stent. Background Coronary lesions involving complex anatomy, including aneurysmatic, ec
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::467d293c09816b3e8eb097a58d102da1
http://europepmc.org/articles/PMC5910317
Zobrazit plný text záznamu
4
Does the novel delivery system for the STENTYS self-apposing coronary stent increase the risk of stent edge dissections? Optical coherence tomography post stent findings
Autor: Maik J. Grundeken, Karel T. Koch, Deborah N. Kalkman, Robbert J. de Winter, Jan G.P. Tijssen, Huangling Lu, Joanna J. Wykrzykowska
Publikováno v: Expert review of medical devices, 15(2), 157-165. Taylor and Francis Ltd.
Background: With optical coherence tomography (OCT), details of arterial injuries during percutaneous coronary intervention can be assessed accurately. There might be an increased risk of stent edge dissections with the novel delivery system for the
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1aa456f8f1a721f01859e938307eb8fe
https://doi.org/10.1080/17434440.2018.1421942
Zobrazit plný text záznamu
5
Safety and efficacy of the Tryton Side Branch Stent™ for the treatment of coronary bifurcation lesions: an update
Autor: Robbert J. de Winter, Joanna J. Wykrzykowska, Maik J. Grundeken
Publikováno v: Expert review of medical devices, 14(7), 545-555. Taylor and Francis Ltd.
Percutaneous coronary interventions (PCIs) involving coronary bifurcation lesions are associated with adverse outcomes compared with non-bifurcation lesions. The Tryton Side Branch Stent has been developed to improve clinical outcomes after bifurcati
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2de3b6b394b93501d2b2a2406e313412
https://doi.org/10.1080/17434440.2017.1338135
Zobrazit plný text záznamu
6
Regular drug-eluting stents versus the dedicated coronary bifurcation sirolimus-eluting BiOSS LIM® stent: the randomised, multicentre, open-label, controlled POLBOS II trial
Autor: Sławomir Dobrzycki, Radoslaw Formuszewicz, Jacek Bil, Patrick W. Serruys, Luis A Iñigo Garcia, Tomasz Pawłowski, Joanna J. Wykrzykowska, Robert J. Gil, Adam Kern, Dobrin Vassilev, Maik J. Grundeken
Publikováno v: EuroIntervention, 12(11), e1404-e1412. EuroPCR
AIMS The aim of the POLBOS II randomised trial was to compare any regular drug-eluting stents (rDES) with the dedicated bifurcation sirolimus-eluting stent BiOSS LIM for the treatment of coronary bifurcation lesions. The secondary aim was to study th
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c086112a6efcf8652607c8f4ddbdd343
https://doi.org/10.4244/eijy15m11_11
Zobrazit plný text záznamu
7
Long-term effectiveness and safety of the sirolimus-eluting BiOSS LIM® dedicated bifurcation stent in the treatment of distal left main stenosis: an international registry
Autor: Luis A Iñigo Garcia, Robert J. Gil, Tomasz Pawłowski, Dobrin Vassilev, Jacek Bil, Patrick W. Serruys, Joanna J. Wykrzykowska, Maik J. Grundeken, Adam Kern
Publikováno v: EuroIntervention, 12(10), 1246-1254. EuroPCR
AIMS The aim of this study was to assess prospectively the effectiveness and safety of a new version of the dedicated bifurcation BiOSS stent, the sirolimus-eluting BiOSS LIM, for the treatment of distal left main (LM) stenosis. METHODS AND RESULTS T
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8a4b0e6a15c366f5c3103a4bca80acd6
https://doi.org/10.4244/eijy15m10_05
Zobrazit plný text záznamu
8
Two-year clinical outcomes of Absorb bioresorbable vascular scaffold implantation in complex coronary artery disease patients stratified by SYNTAX score and ABSORB II study enrolment criteria
Autor: Jan G.P. Tijssen, Joanna J. Wykrzykowska, José P.S. Henriques, Marije M. Vis, Maik J. Grundeken, Mariëlla E. Hassell, Robin P. Kraak, Jan Baan, Joëlle Elias, Robbert J. de Winter, Karel T. Koch, Jan J. Piek
Publikováno v: EuroIntervention, 12(5), e557-e565. EuroPCR
AIMS This study presents the two-year clinical outcomes of the Amsterdam ABSORB registry stratified by lesion and patient characteristics complexity (SYNTAX score and ABSORB II study enrolment criteria). METHODS AND RESULTS Patients treated with BVS
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7030b26de18f3eeda87f58dfe1ba2979
https://doi.org/10.4244/eijv12i5a95
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje